Board Name | Posts By thttlpckg | Post Created |
---|---|---|
IPIX Innovation Pharmaceuticals Inc | Why would 75% of the patients be gi ![]() | 11/11/2021 4:24:50 PM |
IPIX Innovation Pharmaceuticals Inc | I am hoping for some mouse model te ![]() | 07/15/2021 10:40:32 PM |
IPIX Innovation Pharmaceuticals Inc | A poster on another board listed ly | 11/02/2020 5:59:40 PM |
IPIX Innovation Pharmaceuticals Inc | They changed the wording of the tri ![]() | 11/02/2020 10:17:02 AM |
IPIX Innovation Pharmaceuticals Inc | https://static1.squarespace.com/st ![]() | 04/01/2020 8:07:33 AM |
IPIX Innovation Pharmaceuticals Inc | Wonder if locust would have any pul | 03/24/2020 11:03:21 AM |
IPIX Innovation Pharmaceuticals Inc | Even if brilacidin works for corona ![]() | 03/22/2020 3:04:21 PM |
IPIX Innovation Pharmaceuticals Inc | A poster on an OCAT board I followe | 05/13/2016 11:32:06 AM |
IPIX Innovation Pharmaceuticals Inc | Hi Folks, I have just started doing | 12/16/2015 8:37:48 AM |
Recent Articles
- Transforming Housing in Canada: The Build Canada Homes Initiative
- Federal Initiative to Strengthen Housing Affordability in Canada
- Build Canada Homes: A Revolutionary Step to Affordable Housing
- Elon Musk Addresses Violence Concerns Amid Political Tensions
- Public Perception Contrasts with Trump's Economic Claims
- Apple Reinforces Design Values After Design Team Changes
- Surging Housing Market: Stocks to Watch Amid Interest Shifts
- Alto Neuroscience Investors Alerted to Participate in Case
- Nutex Health Inc. Faces Class Action: Investors Urged to Act
- X Square Robot Secures Investment for Future of Humanoid AI
- Exploring High-Yield Blue Chip Stocks: Opportunities and Risks
- Investigating Securities Violations of Lesaka Technologies, Inc.
- Potential Risks Loom as AI Stock Market Valuations Soar
- Novo Nordisk Investors Urged to Join Class Action for Compensation
- Mark Cuban Defends Steve Ballmer Amid Clippers Controversy
- Build Canada Homes Initiative Set to Revolutionize Housing Market
- Charlie Javice Takes Accountability for $175 Million Fraud Case
- Understanding the Psychological Impact of AI on Users
- Trump Engages TikTok Advocating Accountability for Media
- Understanding Economic Inequality Through Robert Reich's Lens
- Rent Surges in NYC’s Top Neighborhoods Amid Economic Shifts
- Navigating Investor Rights: Semler Scientific Case Update
- Trump Intensifies Rhetoric Against Soros Amid Controversy
- Breast Cancer Antibody Drug Conjugates: Opportunities Ahead
- Important Update for SelectQuote, Inc. Investors on Class Action
- Cornelius D. Jones Joins Prestigious Academy of Authors
- Lantheus Holdings Faces Class Action: Investors Urged to Act
- Hyundai's Supernal Faces Leadership Changes, Future Uncertain
- Larry Ellison: From College Dropout to Tech Titan
- Gold Producers Tackle Emissions with Mixed Results in ESG Metrics
- China's Potential Ban on Flush Door Handles in Cars
- Market Insights: Top 10 Large Cap Stocks Facing Declines
- Crypto Landscape Shifts: Ethereum ETFs Surge Amid Market Changes
- Investigating PACS Group, Inc.: Shareholder Concerns Addressed
- Pomerantz Law Firm Launches Investigation on Freeport-McMoRan
- Quanex Building Products Faces Potential Investor Claims Today
- Geely Automobile Holdings: Investor Concerns and Legal Steps
- MarineMax, Inc. Investors: Key Insights and Updates for HZO
- Matrix Service Company Faces Scrutiny Over Investor Claims
- Pomerantz Law Firm Investigates Potential Securities Fraud by BellRing Brands
- Bumble Inc. Faces Legal Scrutiny Over Potential Securities Violations
- Pomerantz Law Firm Launches Investigation into Agilon Health
- Pomerantz Law Firm Reviews Securities Claims Against Synopsys
- Investor Investigation: Duolingo, Inc. Faces Claims and Trends
- Insperity, Inc. Under Investigation for Possible Securities Fraud
- Class Action Filed Against Dow Inc. by Pomerantz Law Firm
- Concerns Rise as Pomerantz Law Firm Investigates Fluor Corp
- Big Week for Large-Cap Stocks: Top Gainers You Can't Miss
- Celebrating Everlight Solar: Madison's Top Choice in 2025
- Invest in Capricor Therapeutics: Upcoming Class Action Deadline